Inventiva IVA
NASDAQ IVA
$3.68 +0.39 (+12.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Inventiva (IVA) Capital Expenditures (2021 - 2026)

Updated

Inventiva's Capital Expenditures came in at -$195,277 for Q2 2026, compared with -$64,522 a year earlier.

Analysis

Inventiva (IVA) Capital Expenditures (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Inventiva reported Capital Expenditures of -$675,305; for FY2025, it came in at -$287,519.

  • Going back by year, Capital Expenditures was -$355,842 in FY2024, -$581,008 in FY2023, -$572,359 in FY2022 and -$631,934 in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Inventiva 635.75 Mn 635.75 Mn - -195,276.79
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -195,276.79
Jun 30, 2025 -64,521.70
Jun 30, 2024 -274,606.33
Jun 30, 2021 -140,899.76
Mar 31, 2021 -49,455.68
API Access

Inventiva Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IVA&period=max&api_key=YOUR_API_KEY